会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Systems, methods, and computer program product for real estate value analysis
    • 用于房地产价值分析的系统,方法和计算机程序产品
    • US08650067B1
    • 2014-02-11
    • US12037168
    • 2008-02-26
    • Richard Moss
    • Richard Moss
    • G06Q10/00
    • G06Q30/0201
    • Methods, apparatus, and computer-readable media are described for generating a credible market value that is utilized to produce a listing price for a property with reduced risk of a substantial reduction in the listing price before selling the property and for assessing risk of incorrectly pricing a property. A subject property, selected comparables, and selected comparables having multiple sales are imported from one or more databases for analysis. Information that is imported may include, for example, property features, original listing prices, record of days on the market, and a final listing price and sales price for each property that was sold. A market analysis process is run to produce relative market assessments and a residential value process is run including appreciation calculations based on the comparable properties having multiple sales to produce the credible market value. Graphs are plotted and other computer outputs are provided to identify the risk of incorrectly pricing a property and to illustrate that risk to a potential seller. Additionally, tools are provided to readily illustrate how changes in underlying assumptions affect the analysis.
    • 描述了用于产生可信的市场价值的方法,装置和计算机可读介质,所述市场价值用于为出售物业而在降低上市价格的风险降低的风险下生产上市价格以及评估不正确定价的风险 一个财产 从一个或多个数据库导入具有多个销售的主题属性,选定的可比较和选定的可比较项以进行分析。 进口的信息可能包括,例如,财产特征,原始上市价格,市场上的天数,以及每个出售物业的最终上市价格和销售价格。 进行市场分析过程以产生相对的市场评估,并且运行住宅价值流程,包括基于具有多个销售的可比性质的升值计算以产生可信的市场价值。 绘制图形,并提供其他计算机输出,以确定对物业进行不正确定价的风险,并向潜在卖方说明风险。 此外,还提供了工具,以便轻松地说明底层假设的变化如何影响分析。
    • 5. 发明申请
    • Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
    • 治疗和监测炎症和氧化还原不平衡囊性纤维化的方法
    • US20070049641A1
    • 2007-03-01
    • US11507706
    • 2006-08-22
    • Rabindra TirouvanziamLenore HerzenbergLeonard HerzenbergCarol ConradRichard Moss
    • Rabindra TirouvanziamLenore HerzenbergLeonard HerzenbergCarol ConradRichard Moss
    • A61K31/198
    • A61K31/198A61K45/06A61K2300/00
    • The present invention relates to pharmaceutical kits and methods to treat lung inflammation and redox imbalance in human cystic fibrosis patients using pharmaceutical compositions containing N-acetylcysteine (NAC), pharmaceutically acceptable salts of N-acetylcysteine, or N-acetylcysteine derivatives. In phase I studies, treatment with oral NAC at a dose of from about 1800 mg/day to about 3000 mg/day for a period of 4 weeks produced significant positive effects, namely, it decreased absolute numbers of white blood cells and neutrophils in the sputum and produced concomitant decreases in sputum neutrophil elastase specific activity and sputum interleukin-8 levels, suggesting an amelioration of lung inflammation in the patients. These effects were associated with an increased total GSH level in whole blood as well increased staining for reduced GSH in blood neutrophils, both of which reflect an amelioration of the redox imbalance in the patients. In ongoing phase II studies, oral NAC at a dose of about 2700 mg/day administered in double-blind manner for 12 weeks showed excellent safety and significantly decreased white blood cells in sputum as compared to placebo.
    • 本发明涉及使用含有N-乙酰半胱氨酸(NAC),N-乙酰半胱氨酸或N-乙酰半胱氨酸衍生物的药学上可接受的盐的药物组合物治疗人囊性纤维化患者的肺部炎症和氧化还原失衡的药物试剂盒和方法。 在I期研究中,口服NAC以约1800mg /天至约3000mg /天的剂量治疗4周产生显着的积极作用,即,其中白细胞和嗜中性粒细胞的绝对数量减少 痰液产生痰中性粒细胞弹性蛋白酶比活性和痰白细胞介素-8水平的伴随降低,表明患者肺部炎症改善。 这些影响与全血中GSH总量的增加有关,同时也增加了血液嗜中性粒细胞GSH降低的染色,这两者都反映了患者氧化还原失衡的改善。 在正在进行的II期研究中,与安慰剂相比,以双盲方式施用12周的剂量为约2700mg /天的口服NAC显示优异的安全性并显着降低痰中的白细胞。
    • 7. 发明授权
    • Medical cassette for ambulatory medical infusion pumps with access port
for reservoir bags and method of resupplying bags in said cassette
    • 用于具有用于储存袋的进入口的移动医用输液泵的医疗盒和在所述盒中重新供应袋的方法
    • US5336190A
    • 1994-08-09
    • US106054
    • 1993-08-12
    • Richard MossFred Erlich
    • Richard MossFred Erlich
    • A61M5/142A61M1/00
    • A61M5/142A61M2205/12
    • A method for resupplying a cassette assembly (14) for an ambulatory medical infusion pump (10) with a new reservoir bag (22a) includes the steps of substantially emptying a used reservoir bag (22) located within said cassette interior (27) of any fluid, supplying an access slot (40) to the interior (27) of the cassette large enough to withdraw the used drug reservoir bag (22) from within the cassette, removing a luer lock (34) located at the end of microbore tubing (32) attached to the reservoir bag, removing the tubing (32) from under a guide retainer (30) in a pumping plate (16) of the cassette, withdrawing the reservoir bag (22) from the access slot (40), inserting a new unused reservoir bag (22a) into the access slot (40) to the interior of said cassette, by inserting a tube (32a) of a new unused reservoir bag and pulling the tube (32a) such that the bag (22a) is pulled through the slot (40) and into the interior (27) of the cassette shell (18).
    • 一种用于为具有新的贮存袋(22a)的流动医用输液泵(10)重新供应盒组件(14)的方法包括以下步骤:将位于所述盒内部(27)内的所使用的储存袋(22)基本上排空, 向盒的内部(27)供应大的入口槽(40),其大到足以从盒内取出使用过的药物储存袋(22),去除位于微孔管端部的鲁尔锁(34) 32),其从所述盒的抽吸板(16)中的引导保持器(30)下方从所述进入狭槽(40)中抽出所述储存袋(22),从所述存储袋(40)中取出所述管道(32) 通过插入新的未使用的储存袋的管(32a)并拉动管(32a)使得袋(22a)被拉动,新的未使用的储存袋(22a)进入到所述盒的内部的入口槽(40) 通过狭槽(40)并进入盒壳体(18)的内部(27)。